Riskpilot← Back to searchSign inGet full accessKF af 1. november 2023 ApS
APSIn liquidationCVR 15278692Birkholmsvej 23Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19911 employees
Revenue 2022
DKK 300K
-47% vs 2021
EBITDA margin
20.5%
-81% vs 2021
Equity ratio
72.3%
Financial strength
Net profit 2022
DKK 41K
-83% vs 2021
| Revenue | DKK 300K | -47% |
| EBITDA | DKK 62K | -81% |
| Net profit | DKK 41K | -83% |
| Total assets | DKK 884K | -24% |
| Equity | DKK 638K | -24% |
| Employees | 1 | — |
Legal name
KF af 1. november 2023 ApS
CVR number
15278692
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 1991
Share capital
DKK 210.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Birkholmsvej 23
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 458 | 294 | 481 | 566 | 300 |
| Staff expenses | -243 | -238 | -238 | -245 | -239 |
| EBITDA | 215 | 56 | 243 | 321 | 62 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 215 | 56 | 243 | 321 | 62 |
| Net financials | -3 | -3 | -4 | -8 | -8 |
| Profit before tax | 212 | 53 | 238 | 313 | 54 |
| Tax | 47 | 12 | 88 | 69 | 12 |
| Net profit | 165 | 41 | 150 | 244 | 41 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1.231 | 1.151 | 1.461 | 1.163 | 884 |
| Equity | 1.002 | 893 | 894 | 837 | 638 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 229 | 258 | 568 | 326 | 245 |
| Total debt | 229 | 258 | 568 | 326 | 245 |
EBITDA margin
20.5%
This company
15.8%
Market median
+30% vs market
20182022
Equity ratio
72.3%
This company
38.2%
Market median
+89% vs market
20182022
Return on equity
6.5%
This company
18.4%
Market median
-65% vs market
20182022
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20182022
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20182022
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20182022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (6) | ||
AM | Audit | 1998 – 2010 |
ET | Audit | 1991 – 1992 |
JH Management | Management | 1991 – 2010 |
MP Unofficial title | Unofficial title | 2023 – 2024 |
CH Management | Management | 2009 – 2023 |
PE Management | Management | 1991 – 1992 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2012 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2012 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KF af 1. november 2023 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Michael Ankjær-Jensen | Audit | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Jørgen Hede-Andersen | Management | 0 companies |
| Marianne Philip | Unofficial title | 0 companies |
| Christian Hede-Andersen | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |